Cantor Fitzgerald Starts Surrozen Inc. (SRZN) at Overweight Feb 19, 2026 06:10AM
Surrozen (SRZN) reported Q3 result Nov 11, 2025 12:28AM
Surrozen (SRZN) Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway May 14, 2025 08:31AM
Surrozen (SRZN) Misses Q3 EPS by 743c May 9, 2025 05:05PM
Surrozen (SRZN) Announces Oversubscribed $175M Private Placement Mar 24, 2025 09:01AM


Jan 30, 2025 06:07AM H.C. Wainwright Starts Surrozen Inc. (SRZN) at Buy, PT $32
Nov 4, 2024 08:32AM Surrozen (SRZN) and TCGFB Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis
Sep 24, 2024 08:31AM Surrozen (SRZN) Earns $10M Milestone Payment in Retinal Diseases Collaboration
Aug 13, 2024 04:23PM Surrozen (SRZN) Misses Q2 EPS by 799c
Jun 10, 2024 08:30AM Surrozen (SRZN) Presents Preliminary Results from Phase 1a Study of SZN-043